UNSPSC 51142502: Carbidopa

This classification denotes a dopamine agonist and antiparkinsonian agent with the molecular formula C10H14N2O4.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MNX7R8C5VO, chemically known as hydrocinnamic acid, .alpha.-hydrazino-3,4-dihydroxy-.alpha.-methyl-, l- but generally known as carbidopa, which bears US NIH Compound Identifier 2563. Carbidopa most often comes in base, anhydrous, and hydrate forms, and is often combined with Levodopa.

UNSPSC 51142502 Carbidopa (Commodity) shows minimal relevant recent activity in state and local procurement. The three opportunities posted under this code between April and August 2026 include a District Attorney's Office dog procurement by Washington County, Oregon; athletic training services for public safety personnel by the City of Tucson; and medical aid supplies by the City of Tampa Fire Rescue Department. None of these solicitations involve carbidopa or pharmaceutical procurement aligned with the code's nominal scope. The mismatch suggests either tagging error in the source data or that this code does not reflect active state and local buying patterns for this medication.

Without verified opportunities matching carbidopa's actual pharmaceutical scope, the code does not support a meaningful market characterization for business development purposes at this time. Firms pursuing pharmaceutical supply contracts with state and local entities should confirm the correct UNSPSC family or commodity code through direct engagement with procurement offices rather than relying on this code's current activity signal.